SPES Pharma

About:

Pharmaceutical Development, 505b2, New Drug Delivery Technology

Description:

SPES is a specialty pharmaceutical company focusing on patient medical needs through innovative science and technologies. The company is developing twelve 505(b)(2) products based on three innovative platforms. The candidate products are targeting therapeutic areas including oncology, antiemetic, CNS, and pain management to provide patients with safer and more efficient treatment options.

Total Funding Amount:

$2M

Headquarters Location:

North Brunswick, New Jersey, United States

Founded Date:

2017-01-09

Contact Email:

spescorp(AT)spespharma.com

Founders:

Jianwei Yu, Luke Wang

Number of Employees:

1-10

Last Funding Date:

2017-06-20

IPO Status:

Private

Industries: